ACVR2B and idiopathic pulmonary fibrosis: Binding simulations further revealed that our peptides occupy the Activin A binding region, and are thus critical for interactions with its receptor ActRIIB and its natural inhibitor, follistatin (Figure 2 and Figure 3), suggesting their potential in disrupting pathological signaling pathways effectively in IPF [20,47,48].